Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 November 2021 | Story Dr Nitha Ramnath | Photo Supplied


“Running provides me with a platform to reach others, to bring hope, to make people realise that anything is possible if you are prepared to work hard for it,” says Louzanne Coetzee, our very own home-grown all-round achiever, who is fun-loving, relatable, and inspiring. A South African para-athlete, Coetzee was born blind as a result of a hereditary condition called Leber congenital amaurosis, and competes in the T11 disability class for athletes with the highest level of visual impairment. Coetzee enjoys an integrated life, with an interest in baking, watching movies, walking and hiking, cycling, being part of a church band, public speaking, coupled with some artistic hobbies.

Our podcast guest

Coetzee competed at the 2020 Tokyo Paralympic Games this year, where she won a silver medal in the 1 500 m final alongside her guide Erasmus Badenshorst, setting a new African record of 4:40.96. She also competed in the women’s mixed class marathon (T11 and T12 for the visually impaired) with her guide Claus Kempen, improving the world record by 1 min 42 sec and her personal best from 3:13:41 to 3:11:13. 

In 2018, Coetzee competed in three events at the Para Athletics event in Berlin, Germany – the 800 m, 1 500 m, and 5 000 m. She set a new African record in the T11 800 m race, taking the silver medal, as well as a bronze for the 1 500 m race. In 2018, Coetzee also broke the 5 000 m (women) world record in her disability class, while in the same year she became the first visually impaired athlete to compete at the World University Cross Country Championships in Switzerland. 
Coetzee set a new world record in the 5 000 m T11 category for the first time at the Nedbank National Championships for the Physically Disabled in March 2016. Moreover, with her performance of 19:17.06, Coetzee shattered the Lithuanian athlete Sigita Markeviciene’s 16-year record of 20:05.81, set at the 2000 Paralympics in Sydney. Coetzee became the first totally blind female to clock sub-20 minutes in the 5 000 m.

Her involvement in her society stretches beyond sports, and as a student, she formed part of the University of the Free State Student Representative Council. She was also an athlete representative on the Free State Academy of Sport’s executive committee.

In 2014, she became the first visually impaired student to be elected to the UFS Student Representative Council (SRC), with the portfolio Student Accessibility. From 2015 to 2017, she was a research assistant in the Institute for Reconciliation and Social Justice at the UFS, and in 2016 she also acted as junior lecturer in a computer module for students with visual impairments. From 2017 to 2018, she was Residence Head of Arista Ladies City Residence, and she is currently the Residence Head of Akasia Residence at the UFS.  

Coetzee boasts several accolades from the UFS. She was named the 2014 Senior Sportswoman of the Year by the Free State Sport Association for the Physically Disabled (FSSAPD). In 2017, she and her guide Khothatso Mokone received a Special Award for Disabled Sport at the KovsieSport Awards. In 2018, she won the Free State Sports Star Award, and was named Sports Star of the Year (period June 2018 to April 2019) by the Free State Sport Association for the Physically Disabled. 

Coetzee’s academic qualifications include a BA and BAHons in Integrated and Corporative Marketing Communication, and an MA in Social Cohesion and Reconciliation – all from the University of the Free State. 
Listen to the podcast  below

François van Schalkwyk and Keenan Carelse, UFS alumni leading the university’s United Kingdom Alumni Chapter, have put their voices together to produce and direct the podcast series.  Intended to reconnect alumni with the university and their university experience, the podcasts will be featured on the first Monday of every month, ending in November 2021.  Our featured alumni share and reflect on their experiences at the UFS, how it has shaped their lives, and relate why their ongoing association with the UFS is still relevant and important. The podcasts are authentic conversations – they provide an opportunity for the university to understand and learn about the experiences of its alumni and to celebrate the diversity and touchpoints that unite them. 

For further information regarding the podcast series, or to propose other alumni guests, please email us at alumnipodcast@ufs.ac.za 

For all Voices from the Free State podcasts, click here 
    

News Archive

Link between champagne bubbles and the UFS?
2012-11-16

Prof. Lodewyk Kock with an example of a front page of the publication FEMS Yeast Research, as adapted by F. Belliard, FEMS Central Office.
Photo: Leatitia Pienaar
15 November 2012

What is the link between the bubbles in champagne and breakthrough research being done at the Mayo Clinic in America? Nano research being done at our university.

Prof. Lodewyk Kock of Biotechnology says a human being consists of millions of minute cells that are invisible to the eye. The nano technology team at the UFS have developed a technique that allows researchers to look into such a cell, as well as other microorganisms. In this way, they can get an idea of what the cell’s “insides” look like.

The UFS team – consisting of Profs. Kock, Hendrik Swart (Physics), Pieter van Wyk (Centre for Microscopy), as well as Dr Chantel Swart (Biotechnology), Dr Carlien Pohl (Biotechnology) and Liza Coetsee (Physics) – were amazed to see that the inside of cells consist of a maze of small tunnels or blisters. Each tunnel is about 100 and more nanometres in diameter – about one ten thousandth of a millimetre – that weaves through the cells in a maze.

It was also found that these tunnels are the “lungs” of the cells. Academics doing research on yeast have had to sit up and take notice of the research being done at the UFS – to the extent that these “lungs” will appear on the front page of the highly acclaimed FEMS Yeast Research for all of 2013.

The Mayo Clinic, in particular, now wants to work with the UFS to study cancer cells in more detail in order to fight this disease, says Prof. Kock. The National Cancer Institute of America has also shown interest. This new nano technology for biology can assist in the study and development of nano medicine that can be used in the treatment of cancer and other life threatening diseases. Nano medicine uses nano metal participles that are up to one billionth of a metre in size.

Prof. Kock says laboratory tests indicate that nano medicine can improve the efficacy of anti-cancer medicine, which makes the treatment less toxic. “According to the Mayo Clinic team, nano particles are considered as a gold cartridge which is being fired directly at a cancer tumour. This is compared to fine shot that spreads through the body and also attacks healthy cells.”

“This accuracy implies that the chemotherapy dose can be lowered with fewer side effects. The Mayo Clinic found that one-tenth of the normal dosage is more effective against pancreas cancer in this way than the full dosage with a linkage to nano particles. According to the clinic, this nano medicine could also delay the spread of cancer,” says Prof. Kock.

The nano particles are used as messengers that convey anti-cancer treatment to cancer cells, where it then selectively kills the cancer cells. The transport and transfer of these medicines with regard to gold nano particles can be traced with the UFS’s nano technology to collect more information, especially where it works on the cell.

“With the new nano technology of the UFS, it is possible to do nano surgery on the cells by slicing the cells in nanometre thin slices while the working of the nano medicine is studied. In this way, it can be established if the nano medicine penetrates the cells or if it is only associated with the tiny tunnels,” says Prof. Kock.

And in champagne the small “lungs” are responsible for the bubbles. The same applies to beer and with this discovery a whole new reach field opens for scientists.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept